These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 30336768)
21. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer. Qi Y; Qi H; Liu Z; He P; Li B J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359 [TBL] [Abstract][Full Text] [Related]
22. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer. Yue Y; Zhang Q; Sun Z Front Immunol; 2021; 12():758040. PubMed ID: 35140706 [TBL] [Abstract][Full Text] [Related]
23. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
24. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma. Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384 [TBL] [Abstract][Full Text] [Related]
25. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer. Yu C; Hong H; Zhang S; Zong Y; Ma J; Lu A; Sun J; Zheng M Mol Med Rep; 2019 Mar; 19(3):2065-2076. PubMed ID: 30664178 [TBL] [Abstract][Full Text] [Related]
26. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer. Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687 [TBL] [Abstract][Full Text] [Related]
27. Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis. Li S; Li T; Shi YQ; Xu BJ; Deng YY; Sun XG Cancer Biomark; 2024; 40(1):27-45. PubMed ID: 38393891 [TBL] [Abstract][Full Text] [Related]
28. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas. Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980 [TBL] [Abstract][Full Text] [Related]
29. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival. Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034 [TBL] [Abstract][Full Text] [Related]
30. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data. Xiong Y; You W; Wang R; Peng L; Fu Z Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625 [TBL] [Abstract][Full Text] [Related]
31. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer. Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510 [TBL] [Abstract][Full Text] [Related]
32. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743 [TBL] [Abstract][Full Text] [Related]
33. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer. Liang Y; Zhang C; Ma MH; Dai DQ World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274 [TBL] [Abstract][Full Text] [Related]
34. FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc. Yu Y; Guo M; Wei Y; Yu S; Li H; Wang Y; Xu X; Cui Y; Tian J; Liang L; Peng K; Liu T Oncotarget; 2016 Dec; 7(49):80888-80900. PubMed ID: 27825133 [TBL] [Abstract][Full Text] [Related]
35. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis. Wang Q; Yu C Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496505 [TBL] [Abstract][Full Text] [Related]
36. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis. Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306 [TBL] [Abstract][Full Text] [Related]
37. Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence. Wu Z; Liu Z; Ge W; Shou J; You L; Pan H; Han W Cancer Med; 2018 Jun; 7(6):2555-2566. PubMed ID: 29659199 [TBL] [Abstract][Full Text] [Related]
38. Identification and validation of cetuximab resistance associated long noncoding RNA biomarkers in metastatic colorectal cancer. Peng K; Liu R; Yu Y; Liang L; Yu S; Xu X; Liu T Biomed Pharmacother; 2018 Jan; 97():1138-1146. PubMed ID: 29136952 [TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis. Lin J; Wu G; Zhao Z; Huang Y; Chen J; Fu C; Ye J; Liu X Mol Med Rep; 2018 Dec; 18(6):5594-5602. PubMed ID: 30365099 [TBL] [Abstract][Full Text] [Related]
40. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis. Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]